Clinical Trials Browser

Uterine Cervical Dysplasia × human papillomavirus vaccine, L1 type 16, 18 × Clear all

NCT03105856 2020-08-10

FASTER

Phase 4 Completed

Uterine Cervical Dysplasia

NCT00128661 2019-03-08

Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants

Phase 3 Completed

7,466 enrolled 24 charts

GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

NCT00337818 2017-05-30

Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women

Phase 3 Completed

770 enrolled 12 charts

Uterine Cervical Dysplasia

NCT00316706 2012-09-18

Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine

Phase 3 Completed

1,245 enrolled 11 charts

Uterine Cervical Dysplasia, Papillomavirus Infections